Cannabinoids and Medicinal Benefits Flashcards

1
Q

What is the ECS well established for?

A

A target for therapy of pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What system is the ECS apart of?

A

The endogenous antinociceptive system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does CBR stand for?

A

Cannabinoid Receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where are these CBRs located?

A

Peripheral, spinal, and supraspinal neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do the CBRs do in these specific neurons?

A

Supress nociceptive transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where are CBRs present?

A

Immune cells and regulate inflammatory responses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the CBR ligands an alternative for?

A

Opiods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is there risk with the administration of drugs targeting the ECS? What cannabinoid receptor in particular?

A

Yes, it comes with the risk of cognitive adverse effects/ disruption of the ECS regulation of reward system.

In particular, it is the issue with the CB1 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What prevents seizures?

A

Convential anti-epileptic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does these anti-elipetic drugs do in particular?

A

Block sodium or calcium channels, OR enhance GABA function to reduce the release of excitatory glutamte.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does GABA stand for?

A

Gamma-aminobutyric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the major side-effects of anti-eplieptic drugs?

A

-Impairment of motor function
-Cognitive dysfunction
-Emotional lability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What specific cannabinoids have evidence of potentially reducing seizures?

A

THC and other CB1 agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When and who was the main source of discovering the cannabinoids that could help with seizures?

A

Chesher, Jackson, and Starmer in 1974

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In 1973, (a) how did they administer the test to observe how THC effected seizures? (b) What animals did they test on? (c) Who wrote this paper?

A

(a) Orally (160-200 mg/kg doses)
(b) Mice
(c) Boggan, Steele, and Freedman

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What other CB1 agonist decreased the seizure severity in rodent models?

A

WIN55,212

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does CB1 act synergistically with? And acts as a co-administor with what? What did this do as a result?

A

The 5-HT2B receptor and acts as a co-administor of WIN55,212 and 5-HT2B agonist RO60-0175. As a result it decreased seizures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What inhibition results in anti-seizure activity?

A

Monoacylglycerol, with 2-AG activating CB1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What happens in FAAH inhibition?

A

Leads to increase in intracellular AEA levels and leads to pro-seizure activitiy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What was the greatest succces in treating seizures?

A

CBD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Does RO60-0175 have any effect on seizure patients on its own?

A

No.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Increase of what two endocannabinoids would potentially be seen as an anti-seizure treatment?

A

AEA and A2-G

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Inhibition of what metabolic enzyme causes more seizure activity?

A

FAAH inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Inhibition of what endocannabinoid causes a decrease in seizure activity?

A

Anadamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is an oral solution containing CBD?

A

Epidiolex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the two forms of epliepsy?

A

-Lennox-Gastaut syndrome
-Dravet syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is negative allosteric modulation?

A

A substance that, by binding to a receptor at site other than the primary site, instead reduces the activity of the ligand that normally binds to the site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is rimonabant known for?

A

Anti-obesity agent. A potent CB1 inverse agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What did rimonabant cause? Was it withdrawn from the market?

A

Depression and anxiety. Yes it was withdrawn from the market due to those reasons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What can targeting the ECS do?

A

Could be a potential strategy to design novel psychotic drugs, including anxiolytics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What would be a natural CB1 agonist?

A

THC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What was supposed to be a promising direction to develop a new class of anxiolytic drugs?

A

CB1 Agonists

33
Q

What is one of the the methods in order to reduce anxiety in patients?

A

Inhibit eCB degrading enzymes in order to indirectly activate CB1 by 2-AG or AEA

34
Q

What did FAAH overexpression in hippocampal nuerons show?

A

Decreased levels in AEA in the hippocampus and resulted in anxiety-like behavior.

35
Q

How did they study the ability to reduce anxiety in rodents?

A

Scientists gave rodents NMDA in order to induce anxiety like behavior, then introduced the URB602 (an MAGL inhibitor) in order to to block MAGL and increase the 2-AG in the blood stream in order to reduce anxiety like behavior.

36
Q

What is NMDA?

A

N-methyl-D aspratate

37
Q

What is the strategy that includes the ECS in order to target depressive disorders?

A

Direct or indirect CB1 activation

38
Q

What is a CB1 and CB2 agonist that prevented anhedonia in a rodent model? What is the concentration?

A

WIN55,212-2 (0.5 mg/kg)

39
Q

What is anhendonia?

A

Inability to feel pleasure

40
Q

What is targeted in depressive disorders?

A

eCB degrading enzymes

41
Q

In a rodent model what prevented anhedonia? What was the concentration?

A

FAAH inhibitor, URB597. 0.3 mg/kg

42
Q

What is indirect activation?

A

By inhibiting degrading enzymes

43
Q

Which strain of cannabis is known for a mild potential for addiction?

44
Q

What is a way to potentially omit the problem of addiction?

A

CB1neutral antagonists

45
Q

What was tested in rodent models of opiod addiction? What did it also decrease in mice?

A

AM4113. It also decreased alcohol consumption.

46
Q

What can be helpful for withdrawal symptoms?

A

CB1 agonists

47
Q

What also increase eCB levels?

A

Physical exercise, this can also be part of the treatment of withdrawl syndromes

48
Q

What is the second most prominent target in ECS for fighting the addiction?

49
Q

What increased ethanol intake?

A

CB2 antagonist (AM630)

50
Q

What decrease ethanol intake?

A

CB2 agonist (JWH133)

51
Q

Where can CB2 also be found?

52
Q

What happens when combining CB1 antagonism with CB2 agonism?

A

May be a reasonable strategy for fighting addiction because of recent finding that opposing action on these two receptors has a synergistic effect on reward processing?

53
Q

What activation impairs memory?

A

CB1 activation

54
Q

What enhances memory?

A

CB1 antagonists

55
Q

What are symptons of tramatic brain injury (TBI)?

A

Impaired spacial learning and memory

56
Q

What is the impaired spacial learning and memory connected to?

A

Increased 2-AG levels

57
Q

What did the administartion of CB1 antagonist AM281 in mice do?

A

Ameliorates symptons of impaired spacial learning and memory

58
Q

What did low dosages of Delta-9-THC show?

A

Improved cognitive performance of old mice in which CB1 was crucial

59
Q

What is hormesis?

A

A substance that is typically a problem at higher doses, can be useful at lower doses?

60
Q

What is neurodegeneration?

A

Neuron deteration in brain/CNS

61
Q

What is neurogenesis?

A

The generation of new neurons

62
Q

What takes in part in the regulation of neurogenesis?

A

CB1, CB2, GPR55

63
Q

What is crucial for proligeration and differentiation of neural stem cells?

A

CB1 and GPR55

64
Q

Why may endocannabinoid signaling be beneficial?

A

Impact on attenuating neurotoxicity and neuroinflammation

65
Q

What worsens symptoms in Alzheimer’s disease?

A

CB1 deletion

66
Q

What did the CB1 agonist ACEA exhibit?

A

Anti-apoptotic action on neurons and reduced and cognitive impairment in the Alzheimer’s disease rodent model?

67
Q

What is anti-apoptotic?

A

Anti cell death

68
Q

What does the activation of CB2 do?

A

Leads to anti-inflammatory action

69
Q

Do cannabinoids increase or decrease appetite?

A

Increase appetite

70
Q

How is the increase of appetite mediated?

A

By CB1 activation in the forebrain neurons, hypothalmus and in a mesolimbic dopamine system

71
Q

What does ECS deregulation contribute to?

A

Type 2 Diabetes Mellitus

72
Q

What was shown to reverse diabetic neuropath? Via what?

A

CB1 antagonists (JD5037) via the modulation of glucose transport 2 expression and activity in renal proximal tubule cells.

73
Q

What occurs in diabetes?

A

CB1 receptors are upregulated in the kidney contributing to: renal inflammation, oxidative stress, tubular dysfunction, and glucose reabsorption abnormalitites

74
Q

What does JD5037 not cross? Why is this important? What does this mean about its location?

A

It does not cross the blood-brain barrier. Avoids sides effects such as depression or anxiety that had been seen in examples like rimonabant. This means its localized peripherally.

75
Q

What can happen to the cardiovascular system?

A

Has adverse effect which includes ischemic stroke.

76
Q

What does the modulation of the ECS result in?

A

Alleviation of hypertension, atheroscierosis, mycardial ischemia, and related diseases

77
Q

What did CB1 and CB2 agonists show related to cancer?

A

Shown to elicit antitumor properties both in vitro and in vivo.

78
Q

What is something to look at for a cause of cancers?

A

ECS ovexpression in tumor cells

79
Q

What has shown a positive result in triple negative breast cancer studies? What was the result?

A

A combination with photodynamic therapy with CB2 agonist (JWH-133). This resulted in synergistic inhibition of tumor growth and extended survival time in mice.